Bank of Montreal’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bank of Montreal’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-449	Closed	-$8K	–	4982
2018 Q3	$8K	Sell	449 -13	-3%	-$223	﹤0.01%	4019
2018 Q2	$6K	Buy	+462	New	+$5.48K	﹤0.01%	4112
2017 Q2	–	Sell	-2,002	Closed	-$5K	–	4369
2017 Q1	$5K	Sell	2,002 -215	-10%	-$497	﹤0.01%	3712
2016 Q4	$6K	Buy	2,217 +1,807	+441%	+$5.19K	﹤0.01%	3726
2016 Q3	$1K	Sell	410 -182	-31%	-$567	﹤0.01%	3975
2016 Q2	$2K	Buy	+592	New	+$2.17K	﹤0.01%	3930
2014 Q3	–	Sell	-870	Closed	-$6K	–	4630
2014 Q2	$6K	Buy	870 +270	+45%	+$3.04K	﹤0.01%	4117
2014 Q1	$14K	Buy	+600	New	+$8.7K	﹤0.01%	3589
2013 Q3	–	Sell	-6,500	Closed	-$86K	–	4014
2013 Q2	$86K	Buy	+6,500	New	+$87.6K	﹤0.01%	2482

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Bank of Montreal's ECYT Position: Q4 2018 in Review

Bank of Montreal sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 449 shares — an estimated $8K sold.

Bank of Montreal first reported a position in ECYT in Q2 2013 and held it in 9 quarters. The position peaked at $86K in Q2 2013. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Bank of Montreal reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Bank of Montreal sold 449 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $8K.
Bank of Montreal first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
Bank of Montreal's Endocyte, Inc. Common Stock position peaked at $86K in Q2 2013.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Bank of Montreal's 13F filing for Q4 2018, filed 22 Jan 2019.